Ferumoxytol (Rienso): new intravenous iron preparation

  • Chaplin S
  • Brookes M
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Ferumoxytol (Rienso) is a new intravenous iron formulation for the treatment of iron‐deficiency anaemia in chronic kidney disease. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Dr Matthew Brookes discusses its place in the treatment of iron‐deficiency anaemia.

Cite

CITATION STYLE

APA

Chaplin, S., & Brookes, M. (2013). Ferumoxytol (Rienso): new intravenous iron preparation. Prescriber, 24(9), 25–27. https://doi.org/10.1002/psb.1052

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free